Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma
Clinical trial NCT00257465 · COMPLETED
Trial details
- NCT number
- NCT00257465
- Sponsor
- AVAX Technologies
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2008-06-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.